Misleading Drug Ads Should Be Subject To Financial Penalties, AARP Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress should implement financial penalties for misleading drug ads, AARP Executive Director for State & National Initiatives Christopher Hansen said